Management of Cerebral Edema in Acute Liver Failure

Abstract

Advances in medical care of the acute liver failure patient have led to a significant reduction in mortality related to the condition. Nevertheless, cerebral edema and ensuing brain herniation remains one of the top causes of demise in acute liver failure. Controversy remains regarding the utility of invasive intracranial pressure monitoring as well as usage of novel treatment modalities including therapeutic hypothermia. This review provides a brief summary into the pathophysiology and risk factors for developing cerebral edema in the context of acute liver failure; this review particularly provides a practical focus on general management of the patient with established cerebral edema as well as specific intracranial pressure-lowering strategies.

Keywords

acute liver failure - intracranial hypertension - cerebral edema - neuroprotection - therapeutic hypothermia

Financial Support

None.

• References

• 1 Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013; 369 (26) 2525-2534
• 2 O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97 (02) 439-445
• 3 Blei AT. Medical therapy of brain edema in fulminant hepatic failure. Hepatology 2000; 32 (03) 666-669
• 4 O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342 (8866): 273-275
• 5 Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007; 102 (11) 2459-2463
• 6 Escorsell A, Mas A, de la Mata M. ; Spanish Group for the Study of Acute Liver Failure. Acute liver failure in Spain: analysis of 267 cases. Liver Transpl 2007; 13 (10) 1389-1395
• 7 Wei G, Bergquist A, Broomé U. , et al. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007; 262 (03) 393-401
• 8 Acharya SK, Batra Y, Hazari S, Choudhury V, Panda SK, Dattagupta S. Etiopathogenesis of acute hepatic failure: Eastern versus Western countries. J Gastroenterol Hepatol 2002; 17 (Suppl. 03) S268-S273
• 9 Bernal W, Hyyrylainen A, Gera A. , et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol 2013; 59 (01) 74-80
• 10 Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007; 46 (06) 1844-1852
• 11 Larsen FS, Wendon J. Brain edema in liver failure: basic physiologic principles and management. Liver Transpl 2002; 8 (11) 983-989
• 12 Saksena S, Rai V, Saraswat VA. , et al. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure. J Gastroenterol Hepatol 2008; 23 (7, Pt 2): e111-e119
• 13 Norenberg MD. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. Lab Invest 1977; 36 (06) 618-627
• 14 Jalan R, Olde Damink SW, Hayes PC, Deutz NE, Lee A. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 2004; 41 (04) 613-620
• 15 Kale RA, Gupta RK, Saraswat VA. , et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006; 43 (04) 698-706
• 16 Rai V, Nath K, Saraswat VA, Purwar A, Rathore RK, Gupta RK. Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J Magn Reson Imaging 2008; 28 (02) 334-341
• 17 Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia. Hepatology 2001; 34 (01) 50-54
• 18 Larsen FS, Ejlersen E, Hansen BA, Knudsen GM, Tygstrup N, Secher NH. Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure. J Hepatol 1995; 23 (02) 212-217
• 19 Blei AT. The pathophysiology of brain edema in acute liver failure. Neurochem Int 2005; 47 (1-2): 71-77
• 20 Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 1987; 67 (02) 440-519
• 21 Martinez-Hernandez A, Bell KP, Norenberg MD. Glutamine synthetase: glial localization in brain. Science 1977; 195 (4284): 1356-1358
• 22 Häussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?. J Hepatol 2000; 32 (06) 1035-1038
• 23 Butterworth RF. Hepatic encephalopathy and brain edema in acute hepatic failure: does glutamate play a role?. Hepatology 1997; 25 (04) 1032-1034
• 24 Rama Rao KV, Norenberg MD. Glutamine in the pathogenesis of hepatic encephalopathy: the Trojan horse hypothesis revisited. Neurochem Res 2014; 39 (03) 593-598
• 25 Norenberg MD. Oxidative and nitrosative stress in ammonia neurotoxicity. Hepatology 2003; 37 (02) 245-248
• 26 Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 2006; 44 (04) 788-794
• 27 Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32 (4, Pt 1): 734-739
• 28 Vaquero J, Polson J, Chung C. , et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003; 125 (03) 755-764
• 29 Kato M, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 1992; 15 (06) 1060-1066
• 30 Chastre A, Bélanger M, Nguyen BN, Butterworth RF. Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure. Liver Int 2014; 34 (03) 353-361
• 31 Nguyen JH, Yamamoto S, Steers J. , et al. Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice. J Hepatol 2006; 44 (06) 1105-1114
• 32 Strauss G, Hansen BA, Kirkegaard P, Rasmussen A, Hjortrup A, Larsen FS. Liver function, cerebral blood flow autoregulation, and hepatic encephalopathy in fulminant hepatic failure. Hepatology 1997; 25 (04) 837-839
• 33 Durham S, Yonas H, Aggarwal S, Darby J, Kramer D. Regional cerebral blood flow and CO2 reactivity in fulminant hepatic failure. J Cereb Blood Flow Metab 1995; 15 (02) 329-335
• 34 Czosnyka M, Brady K, Reinhard M, Smielewski P, Steiner LA. Monitoring of cerebrovascular autoregulation: facts, myths, and missing links. Neurocrit Care 2009; 10 (03) 373-386
• 35 Jalan R, , O Damink SW, Deutz NE, Lee A, Hayes PC. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999; 354 (9185): 1164-1168
• 36 Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 1994; 19 (06) 1407-1413
• 37 Ware AJ, D'Agostino AN, Combes B. Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology 1971; 61 (06) 877-884
• 38 Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010; 376 (9736): 190-201
• 39 Blei AT, Larsen FS. Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol 1999; 31 (04) 771-776
• 40 Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999; 29 (03) 648-653
• 41 Kitzberger R, Funk GC, Holzinger U. , et al. Severity of organ failure is an independent predictor of intracranial hypertension in acute liver failure. Clin Gastroenterol Hepatol 2009; 7 (09) 1000-1006
• 42 Muñoz SJ, Moritz MJ, Bell R, Northrup B, Martin P, Radomski J. Factors associated with severe intracranial hypertension in candidates for emergency liver transplantation. Transplantation 1993; 55 (05) 1071-1074
• 43 Wendon J, Cordoba J, Dhawan A. , et al; European Association for the Study of the Liver. Electronic address: [e-mail]; Clinical practice guidelines panel; Panel members; EASL Governing Board representative. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017; 66 (05) 1047-1081
• 44 Bernal W, Auzinger G, Sizer E, Wendon J. Intensive care management of acute liver failure. Semin Liver Dis 2008; 28 (02) 188-200
• 45 Mohsenin V. Assessment and management of cerebral edema and intracranial hypertension in acute liver failure. J Crit Care 2013; 28 (05) 783-791
• 46 Kumar R, , Shalimar, Sharma H. , et al. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clin Gastroenterol Hepatol 2012; 10 (08) 925-931
• 47 Yan S, Tu Z, Lu W. , et al. Clinical utility of an automated pupillometer for assessing and monitoring recipients of liver transplantation. Liver Transpl 2009; 15 (12) 1718-1727
• 48 Muñoz SJ, Robinson M, Northrup B. , et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology 1991; 13 (02) 209-212
• 49 Wijdicks EF, Plevak DJ, Rakela J, Wiesner RH. Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 1995; 70 (02) 119-124
• 50 Vaquero J, Fontana RJ, Larson AM. , et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005; 11 (12) 1581-1589
• 51 Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993; 341 (8838): 157-158
• 52 Karvellas CJ, Fix OK, Battenhouse H, Durkalski V, Sanders C, Lee WM. ; U S Acute Liver Failure Study Group. Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. Crit Care Med 2014; 42 (05) 1157-1167
• 53 Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39 (02) 464-470
• 54 Keays RT, Alexander GJ, Williams R. The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol 1993; 18 (02) 205-209
• 55 Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 2012; 55 (03) 965-967
• 56 Raschke RA, Curry SC, Rempe S. , et al. Results of a protocol for the management of patients with fulminant liver failure. Crit Care Med 2008; 36 (08) 2244-2248
• 57 Lidofsky SD, Bass NM, Prager MC. , et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992; 16 (01) 1-7
• 58 Detry O, Arkadopoulos N, Ting P. , et al. Intracranial pressure during liver transplantation for fulminant hepatic failure. Transplantation 1999; 67 (05) 767-770
• 59 Stravitz RT, Kramer AH, Davern T. , et al; Acute Liver Failure Study Group. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007; 35 (11) 2498-2508
• 60 Shawcross DL, Wendon JA. The neurological manifestations of acute liver failure. Neurochem Int 2012; 60 (07) 662-671
• 61 Scott TR, Kronsten VT, Hughes RD, Shawcross DL. Pathophysiology of cerebral oedema in acute liver failure. World J Gastroenterol 2013; 19 (48) 9240-9255
• 62 Rabinowich L, Wendon J, Bernal W, Shibolet O. Clinical management of acute liver failure: results of an international multi-center survey. World J Gastroenterol 2016; 22 (33) 7595-7603
• 63 Polson J, Lee WM. ; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41 (05) 1179-1197
• 64 Daas M, Plevak DJ, Wijdicks EF. , et al. Acute liver failure: results of a 5-year clinical protocol. Liver Transpl Surg 1995; 1 (04) 210-219
• 65 Larsen FS, Ejlersen E, Clemmesen JO, Kirkegaard P, Hansen BA. Preservation of cerebral oxidative metabolism in fulminant hepatic failure: an autoregulation study. Liver Transpl Surg 1996; 2 (05) 348-353
• 66 Aggarwal S, Brooks DM, Kang Y, Linden PK, Patzer II JF. Noninvasive monitoring of cerebral perfusion pressure in patients with acute liver failure using transcranial Doppler ultrasonography. Liver Transpl 2008; 14 (07) 1048-1057
• 67 Abdo A, Pérez-Bernal J, Hinojosa R. , et al. Cerebral hemodynamics patterns by transcranial Doppler in patients with acute liver failure. Transplant Proc 2015; 47 (09) 2647-2649
• 68 Kawakami M, Koda M, Murawaki Y. Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure. Clin Imaging 2010; 34 (05) 327-331
• 69 Sidi A, Mahla ME. Noninvasive monitoring of cerebral perfusion by transcranial Doppler during fulminant hepatic failure and liver transplantation. Anesth Analg 1995; 80 (01) 194-200
• 70 Kandiah PA, Kumar G. Hepatic encephalopathy—the old and the new. Crit Care Clin 2016; 32 (03) 311-329
• 71 Singanayagam A, Bernal W. Update on acute liver failure. Curr Opin Crit Care 2015; 21 (02) 134-141
• 72 Ravussin P, Guinard JP, Ralley F, Thorin D. Effect of propofol on cerebrospinal fluid pressure and cerebral perfusion pressure in patients undergoing craniotomy. Anaesthesia 1988; 43 (Suppl): 37-41
• 73 Hartung HJ. [Modification of intracranial pressure by propofol (Disoprivan). Initial results]. Anaesthesist 1987; 36 (02) 66-68
• 74 Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000; 32 (03) 536-541
• 75 Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure--a controlled clinical trial. J Hepatol 2004; 41 (01) 89-96
• 76 Bingaman WE, Frank JI. Malignant cerebral edema and intracranial hypertension. Neurol Clin 1995; 13 (03) 479-509
• 77 Citerio G, Vascotto E, Villa F, Celotti S, Pesenti A. Induced abdominal compartment syndrome increases intracranial pressure in neurotrauma patients: a prospective study. Crit Care Med 2001; 29 (07) 1466-1471
• 78 Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 1986; 2 (01) 43-51
• 79 Cardoso FS, Marcelino P, Bagulho L, Karvellas CJ. Acute liver failure: an up-to-date approach. J Crit Care 2017; 39: 25-30
• 80 Scheuermann K, Thiel C, Thiel K. , et al. Correlation of the intracranial pressure to the central venous pressure in the late phase of acute liver failure in a porcine model. Acta Neurochir Suppl (Wien) 2012; 114: 387-391
• 81 Eefsen M, Dethloff T, Frederiksen HJ, Hauerberg J, Hansen BA, Larsen FS. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol 2007; 47 (03) 381-386
• 82 Durward QJ, Amacher AL, Del Maestro RF, Sibbald WJ. Cerebral and cardiovascular responses to changes in head elevation in patients with intracranial hypertension. J Neurosurg 1983; 59 (06) 938-944
• 83 Davenport A, Will EJ, Davison AM. Effect of posture on intracranial pressure and cerebral perfusion pressure in patients with fulminant hepatic and renal failure after acetaminophen self-poisoning. Crit Care Med 1990; 18 (03) 286-289
• 84 Karvellas CJ, Cavazos J, Battenhouse H. , et al; US Acute Liver Failure Study Group. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol 2014; 12 (11) 1942-9.e1
• 85 Winkler SR, Munoz-Ruiz L. Mechanism of action of mannitol. Surg Neurol 1995; 43 (01) 59
• 86 Suarez JI. Hypertonic saline for cerebral edema and elevated intracranial pressure. Cleve Clin J Med 2004; 71 (Suppl. 01) S9-S13
• 87 Harutjunyan L, Holz C, Rieger A, Menzel M, Grond S, Soukup J. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial [ISRCTN62699180]. Crit Care 2005; 9 (05) R530-R540
• 88 Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005; 33 (01) 196-202 , discussion 257–258
• 89 Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000; 28 (09) 3301-3313
• 90 The Brain Trauma Foundation. The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Guidelines for cerebral perfusion pressure. J Neurotrauma 2000; 17 (6-7): 507-511
• 91 Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 2004; 75 (Suppl. 03) iii22-iii28
• 92 Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982; 23 (07) 625-629
• 93 Hanid MA, Davies M, Mellon PJ. , et al. Clinical monitoring of intracranial pressure in fulminant hepatic failure. Gut 1980; 21 (10) 866-869
• 94 García-Morales EJ, Cariappa R, Parvin CA, Scott MG, Diringer MN. Osmole gap in neurologic-neurosurgical intensive care unit: its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med 2004; 32 (04) 986-991
• 95 Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care 2004; 1 (02) 219-233
• 96 Rabinstein AA. Treatment of cerebral edema. Neurologist 2006; 12 (02) 59-73
• 97 Wakai A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2007; (01) CD001049
• 98 Slack AJ, Auzinger G, Willars C. , et al. Ammonia clearance with haemofiltration in adults with liver disease. Liver Int 2014; 34 (01) 42-48
• 99 Davenport A. Continuous renal replacement therapies in patients with liver disease. Semin Dial 2009; 22 (02) 169-172
• 100 Larsen FS, Strauss G, Møller K, Hansen BA. Regional cerebral blood flow autoregulation in patients with fulminant hepatic failure. Liver Transpl 2000; 6 (06) 795-800
• 101 Oshima T, Karasawa F, Satoh T. Effects of propofol on cerebral blood flow and the metabolic rate of oxygen in humans. Acta Anaesthesiol Scand 2002; 46 (07) 831-835
• 102 Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 2002; 34 (04) 1220-1222
• 103 Veroli P, O'Kelly B, Bertrand F, Trouvin JH, Farinotti R, Ecoffey C. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation. Br J Anaesth 1992; 68 (02) 183-186
• 104 Forbes A, Alexander GJ, O'Grady JG. , et al. Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology 1989; 10 (03) 306-310
• 105 Raghavan M, Marik PE. Therapy of intracranial hypertension in patients with fulminant hepatic failure. Neurocrit Care 2006; 4 (02) 179-189
• 106 Polderman KH. Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality--Part 2: Practical aspects and side effects. Intensive Care Med 2004; 30 (05) 757-769
• 107 Rabinstein AA. Treatment of brain edema in acute liver failure. Curr Treat Options Neurol 2010; 12 (02) 129-141
• 108 Strauss G, Hansen BA, Knudsen GM, Larsen FS. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol 1998; 28 (02) 199-203
• 109 Wendon J, Lee W. Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. Neurocrit Care 2008; 9 (01) 97-102
• 110 Ellis A, Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis 1996; 16 (04) 379-388
• 111 Jalan R. Acute liver failure: current management and future prospects. J Hepatol 2005; 42 (1, Suppl): S115-S123
• 112 Vaquero J, Rose C, Butterworth RF. Keeping cool in acute liver failure: rationale for the use of mild hypothermia. J Hepatol 2005; 43 (06) 1067-1077
• 113 Sinclair HL, Andrews PJ. Bench-to-bedside review: hypothermia in traumatic brain injury. Crit Care 2010; 14 (01) 204
• 114 Vaquero J, Bélanger M, James L. , et al. Mild hypothermia attenuates liver injury and improves survival in mice with acetaminophen toxicity. Gastroenterology 2007; 132 (01) 372-383
• 115 Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 2004; 127 (05) 1338-1346
• 116 Córdoba J, Crespin J, Gottstein J, Blei AT. Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis. Gastroenterology 1999; 116 (03) 686-693
• 117 Rose C, Michalak A, Pannunzio M, Chatauret N, Rambaldi A, Butterworth RF. Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure. Hepatology 2000; 31 (04) 872-877
• 118 Chatauret N, Zwingmann C, Rose C, Leibfritz D, Butterworth RF. Effects of hypothermia on brain glucose metabolism in acute liver failure: a H/C-nuclear magnetic resonance study. Gastroenterology 2003; 125 (03) 815-824
• 119 Bernal W, Murphy N, Brown S. , et al. A multicentre randomized controlled trial of moderate hypothermia to prevent intracranial hypertension in acute liver failure. J Hepatol 2016; 65 (02) 273-279
• 120 Karvellas CJ, Todd Stravitz R, Battenhouse H, Lee WM, Schilsky ML. ; US Acute Liver Failure Study Group. Therapeutic hypothermia in acute liver failure: a multicenter retrospective cohort analysis. Liver Transpl 2015; 21 (01) 4-12
• 121 Geurts M, Macleod MR, Kollmar R, Kremer PH, van der Worp HB. Therapeutic hypothermia and the risk of infection: a systematic review and meta-analysis. Crit Care Med 2014; 42 (02) 231-242
• 122 Stravitz RT, Larsen FS. Therapeutic hypothermia for acute liver failure. Crit Care Med 2009; 37 (7, Suppl): S258-S264
• 123 Forman KR, Wong E, Gallagher M, McCarter R, Luban NL, Massaro AN. Effect of temperature on thromboelastography and implications for clinical use in newborns undergoing therapeutic hypothermia. Pediatr Res 2014; 75 (05) 663-669
• 124 Munoz SJ. Hypothermia may impair hepatic regeneration in acute liver failure. Gastroenterology 2005; 128 (04) 1143-1144 , author reply 1144–1145
• 125 Jensen K, Ohrström J, Cold GE, Astrup J. The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochir (Wien) 1991; 108 (3-4): 116-121
• 126 Chung C, Gottstein J, Blei AT. Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis. Hepatology 2001; 34 (02) 249-254
• 127 Tofteng F, Larsen FS. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2004; 24 (07) 798-804
• 128 Clemmesen JO, Hansen BA, Larsen FS. Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin. Hepatology 1997; 26 (06) 1423-1425
• 129 Larsen FS, Hansen BA, Ejlersen E. , et al. Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure. Eur J Gastroenterol Hepatol 1996; 8 (03) 261-265
• 130 Larsen FS, Schmidt LE, Bernsmeier C. , et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 2016; 64 (01) 69-78
• 131 Saliba F, Camus C, Durand F. , et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 2013; 159 (08) 522-531
• 132 Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 1996; 16 (04) 415-425
• 133 Jalan R, Pollok A, Shah SH, Madhavan K, Simpson KJ. Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J Hepatol 2002; 37 (04) 536-538
• 134 Ringe B, Lübbe N, Kuse E, Frei U, Pichlmayr R. Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg 1993; 218 (01) 3-9